Key PointsBristol Myers Squibb has an attractive 4.3% yield, and its P/E is below average for a drug maker.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.
